These final results, together with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the concept of concentrating on ACKR3 as a novel technique to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked Conditions.Determined by out there science t